Can Type 2 Diabetes Be Reversed? Evidence from Clinical Trials

What Does "Reversal" Actually Mean?

The term "reversal" of type 2 diabetes can be misleading. Medically speaking, reversal — often called remission — means achieving blood sugar levels below the diabetic range without the use of glucose-lowering medications. The American Diabetes Association defines remission as an HbA1c below 6.5% sustained for at least three months after stopping diabetes medications.

Importantly, remission does not mean the disease is permanently cured. The underlying susceptibility remains, and blood sugar levels can rise again, particularly if lifestyle changes are not maintained. With that context in mind, the clinical evidence is genuinely encouraging.

The DiRECT Trial: A Landmark Study

One of the most compelling pieces of evidence comes from the Diabetes Remission Clinical Trial (DiRECT), published in The Lancet in 2018. This UK-based trial enrolled 306 adults with type 2 diabetes diagnosed within the previous six years. Participants followed a structured weight management program that included a low-calorie diet (approximately 825–853 calories per day) for 12–20 weeks, followed by gradual food reintroduction and ongoing support.

The results were striking:

• After one year, 46% of participants in the intervention group achieved remission.
• After two years, 36% maintained remission.
• Among those who lost 15 kg or more, nearly 86% achieved remission at one year.

The DiRECT trial demonstrated a clear dose-response relationship between weight loss and remission, reinforcing that excess body fat — particularly around the liver and pancreas — plays a central role in type 2 diabetes development and reversal.

The Twin Cycle Hypothesis

Professor Roy Taylor at Newcastle University, one of DiRECT's lead researchers, proposed the Twin Cycle Hypothesis to explain how remission works. According to this model, excess fat accumulates in the liver, causing insulin resistance and overproduction of glucose. This fat then spills into the pancreas, impairing insulin-secreting beta cells.

When significant weight is lost — especially visceral and ectopic fat — both cycles can be interrupted. Liver fat decreases, hepatic insulin sensitivity improves, and pancreatic beta cell function partially recovers. MRI studies from Taylor's team confirmed that individuals who achieved remission showed measurable reductions in liver and pancreatic fat content.

Bariatric Surgery: The Strongest Evidence

Surgical interventions provide some of the most powerful evidence for diabetes reversal. Studies of bariatric procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy consistently show remission rates of 50–80%, often occurring within days of surgery — before significant weight loss has occurred.

The STAMPEDE trial, published in the New England Journal of Medicine, followed 150 obese adults with poorly controlled type 2 diabetes for five years. Patients who underwent bariatric surgery were far more likely to achieve target HbA1c levels and reduced medication needs compared to those receiving intensive medical therapy alone.

These rapid improvements suggest that hormonal and metabolic changes — not just calorie restriction — contribute significantly to remission after surgery.

Low-Carbohydrate and Very Low-Calorie Diets

Beyond surgery, dietary interventions have shown promise in clinical trials. A 2019 study published in Diabetes Therapy found that a continuous low-carbohydrate diet led to remission in a meaningful proportion of participants after one year. Similarly, very low-calorie diets (VLCDs) mimicking the DiRECT protocol have been adopted in NHS programs across the United Kingdom.

Research suggests that early-stage diabetes and shorter disease duration are the strongest predictors of successful remission. Beta cell function, though impaired, appears to retain enough capacity to recover when metabolic stress is removed.

Who Is Most Likely to Achieve Remission?

Clinical evidence points to several factors that improve the chances of remission:

• Diabetes diagnosed within the last six years
• Significant weight loss of 10–15 kg or more
• Lower baseline HbA1c levels
• Not yet requiring insulin therapy
• Younger age at diagnosis

The Bottom Line

Clinical trials provide compelling, peer-reviewed evidence that type 2 diabetes remission is achievable — and not just theoretically. Through structured weight loss programs, dietary interventions, and bariatric surgery, a significant proportion of people can normalize their blood sugar without medication. While remission is not a permanent cure, it represents a meaningful and life-changing outcome. Anyone interested in pursuing remission should consult their healthcare provider to develop a safe, personalized plan.